|
US20020022056A1
(en)
|
1997-02-14 |
2002-02-21 |
Burkhard Schlutermann |
Oxacarbazepine film-coated tablets
|
|
BR0311327A
(pt)
*
|
2002-05-31 |
2005-02-22 |
Desitin Arzneimittel Gmbh |
Composição farmacêutica contendo oxcarbazepina com liberação sustentada de um ingrediente ativo
|
|
EP1528927A1
(de)
*
|
2002-08-06 |
2005-05-11 |
Novartis AG |
Verwendung von carboxamiden für die behandlung von tinnitus
|
|
GB0221956D0
(en)
*
|
2002-09-20 |
2002-10-30 |
Novartis Ag |
Organic compounds
|
|
AU2004268381B2
(en)
*
|
2003-09-03 |
2009-06-18 |
Novartis Ag |
Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
|
|
AR048672A1
(es)
*
|
2004-03-22 |
2006-05-17 |
Novartis Ag |
Tabletas de desintegracion que comprenden licarbazepina
|
|
JP2008503445A
(ja)
*
|
2004-04-13 |
2008-02-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
便秘患者におけるシメチコンの使用
|
|
WO2006046105A1
(en)
*
|
2004-10-25 |
2006-05-04 |
Ranbaxy Laboratories Limited |
Oxcarbazepine dosage forms
|
|
US20060252745A1
(en)
|
2005-05-06 |
2006-11-09 |
Almeida Jose L D |
Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use
|
|
WO2007008576A2
(en)
*
|
2005-07-08 |
2007-01-18 |
Taro Pharmaceuticals U.S.A., Inc. |
Oxcarbazepine formulation
|
|
WO2007029093A2
(en)
*
|
2005-09-05 |
2007-03-15 |
Ranbaxy Laboratories Limited |
Pharmaceutical dosage forms of oxcarbazepine
|
|
CN101336105A
(zh)
*
|
2006-01-31 |
2008-12-31 |
特瓦制药工业有限公司 |
奥卡西平药物制剂及其制备方法，其中奥卡西平具有宽且多峰的粒度分布
|
|
EP2029118A2
(de)
*
|
2006-01-31 |
2009-03-04 |
Teva Pharmaceutical Industries, Inc. |
Pharmazeutische formulierung von oxcarbazepin und ihr herstellungsverfahren, wobei oxcarbazepin eine breite und multimodale teilchengrössenverteilung aufweist
|
|
ATE496623T1
(de)
*
|
2006-04-26 |
2011-02-15 |
Supernus Pharmaceuticals Inc |
Oxcarbazepin-zubereitungen für kontrollierte freisetzung mit sigmoidalem freisetzungsprofil
|
|
US20080138403A1
(en)
*
|
2006-12-08 |
2008-06-12 |
Sun Pharmaceutical Industries Ltd. |
Pharmaceutical dosage forms of oxcarbazepine
|
|
GB0700773D0
(en)
|
2007-01-15 |
2007-02-21 |
Portela & Ca Sa |
Drug therapies
|
|
WO2008115442A1
(en)
|
2007-03-16 |
2008-09-25 |
Concert Pharmceuticals, Inc. |
Inhibitors of cholesterol ester transfer protein
|
|
US8198305B2
(en)
*
|
2007-04-13 |
2012-06-12 |
Concert Pharmaceuticals Inc. |
1,2-benzisoxazol-3-yl compounds
|
|
KR20100012031A
(ko)
*
|
2007-04-19 |
2010-02-04 |
콘서트 파마슈티컬즈, 인크. |
중수소화된 모르폴리닐 화합물
|
|
WO2008133949A1
(en)
|
2007-04-25 |
2008-11-06 |
Concert Pharmaceuticals, Inc. |
Analogues of cilostazol
|
|
CN102964302B
(zh)
|
2007-05-01 |
2015-10-21 |
康塞特医药品公司 |
吗啡烷化合物
|
|
PL3825306T3
(pl)
|
2007-05-01 |
2023-09-11 |
Sun Pharmaceutical Industries, Inc. |
Związki morfinanu
|
|
US7608737B2
(en)
|
2007-05-01 |
2009-10-27 |
Concert Pharmaceuticasl Inc. |
Naphthyl(ethyl)acetamides
|
|
MX341177B
(es)
|
2007-05-01 |
2016-08-10 |
Concert Pharmaceuticals Inc |
Compuestos de morfina.
|
|
WO2008156632A1
(en)
|
2007-06-12 |
2008-12-24 |
Concert Pharmaceuticals, Inc. |
Azapeptide derivatives
|
|
WO2009051782A1
(en)
*
|
2007-10-18 |
2009-04-23 |
Concert Pharmaceuticals Inc. |
Deuterated etravirine
|
|
AU2009217680B2
(en)
|
2008-02-29 |
2013-09-05 |
Concert Pharmaceuticals, Inc |
Substituted xanthine derivatives
|
|
US20110160253A1
(en)
*
|
2008-05-28 |
2011-06-30 |
Harbeson Scott L |
Deuterated tizanidine
|
|
WO2010019557A1
(en)
*
|
2008-08-12 |
2010-02-18 |
Concert Pharmaceuticals Inc. |
N-phenyl-2-pyrimidineamine derivatives
|
|
DK3248978T3
(da)
|
2008-09-19 |
2019-11-18 |
Concert Pharmaceuticals Inc |
Deutererede morphinanforbindelser
|
|
PL2397158T3
(pl)
|
2008-10-30 |
2016-09-30 |
|
Skojarzone podawanie związków morfinanów oraz leków przeciwdepresyjnych w leczeniu nietrzymania afektu
|
|
WO2010062690A1
(en)
|
2008-10-30 |
2010-06-03 |
Concert Pharmaceuticals Inc. |
Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury
|
|
CN103396473A
(zh)
|
2008-11-04 |
2013-11-20 |
安科治疗公司 |
Cxcr4受体化合物
|
|
US20110313004A1
(en)
|
2008-12-04 |
2011-12-22 |
Concert Pharmaceuticals, Inc. |
Deuterated pyridinones
|
|
US20110053961A1
(en)
|
2009-02-27 |
2011-03-03 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
|
US8563554B2
(en)
|
2009-03-17 |
2013-10-22 |
Concert Pharmaceuticals, Inc. |
Deuterated pyrazinoisoquinoline compounds
|
|
US20120244122A1
(en)
|
2009-05-28 |
2012-09-27 |
Masse Craig E |
Peptides for the Treatment of HCV Infections
|
|
EP2454259A1
(de)
|
2009-06-23 |
2012-05-23 |
Concert Pharmaceuticals Inc. |
Deuterium-modifizierte triazolpyridinderivate als gaba-rezeptormodulatoren
|
|
US20110015154A1
(en)
*
|
2009-07-20 |
2011-01-20 |
Kellermann Gottfried H |
Supporting acetylcholine function
|
|
WO2011047315A1
(en)
|
2009-10-15 |
2011-04-21 |
Concert Pharmaceuticals, Inc. |
Subsitituted benzimidazoles
|
|
US20110098265A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Neuroscience, Inc. |
Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
|
|
WO2011060216A1
(en)
|
2009-11-12 |
2011-05-19 |
Concert Pharmaceuticals Inc. |
Substituted azaindoles
|
|
EP2536696A1
(de)
|
2010-02-18 |
2012-12-26 |
Concert Pharmaceuticals Inc. |
Pyrimidinderivate
|
|
EP2566494B1
(de)
|
2010-02-26 |
2017-11-29 |
Acer Therapeutics, Inc. |
Cxcr4-rezeptorverbindungen
|
|
EP2542534A1
(de)
|
2010-03-02 |
2013-01-09 |
Concert Pharmaceuticals Inc. |
Deuterierte tetrahydronaphthalenderivate
|
|
US8575361B2
(en)
|
2010-03-02 |
2013-11-05 |
Concert Pharmaceuticals Inc. |
Tetrahydronaphthalene derivatives
|
|
US20120208837A1
(en)
|
2010-09-13 |
2012-08-16 |
Roger Tung |
Substituted azaindoles
|
|
WO2012065028A2
(en)
|
2010-11-11 |
2012-05-18 |
Concert Pharmaceuticals Inc. |
Substituted tetracyclines
|
|
WO2012079075A1
(en)
|
2010-12-10 |
2012-06-14 |
Concert Pharmaceuticals, Inc. |
Deuterated phthalimide derivatives
|
|
US8447329B2
(en)
|
2011-02-08 |
2013-05-21 |
Longsand Limited |
Method for spatially-accurate location of a device using audio-visual information
|
|
JP2014506603A
(ja)
|
2011-02-25 |
2014-03-17 |
コンサート ファーマシューティカルズ インコーポレイテッド |
２−アミノ−ナフチリジン誘導体
|
|
WO2012129381A1
(en)
|
2011-03-22 |
2012-09-27 |
Concert Pharmaceuticals Inc. |
Deuterated preladenant
|
|
WO2012151361A1
(en)
|
2011-05-03 |
2012-11-08 |
Concert Pharmaceuticals Inc. |
Carbamoylpyridone derivatives
|
|
US20140128469A1
(en)
|
2011-05-10 |
2014-05-08 |
Concert Pharmaceuticals Inc. |
Deuterated n-butyl bumetanide
|
|
PL2709986T3
(pl)
|
2011-05-18 |
2017-09-29 |
Concert Pharmaceuticals Inc. |
Deuterowane pochodne iwakaftoru
|
|
US20140296263A1
(en)
|
2011-07-19 |
2014-10-02 |
Concert Pharmaceuticals, Inc. |
Substituted xanthine derivatives
|
|
CA2860740A1
(en)
|
2012-01-09 |
2013-07-18 |
Anchor Therapeutics, Inc. |
Apj receptor compounds
|
|
WO2013130849A1
(en)
|
2012-02-29 |
2013-09-06 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
|
EP2836492B1
(de)
|
2012-04-13 |
2018-03-14 |
Concert Pharmaceuticals Inc. |
Substituierte xanthinderivate
|
|
WO2013159026A1
(en)
|
2012-04-20 |
2013-10-24 |
Concert Pharmaceuticals, Inc. |
Deuterated rigosertib
|
|
ES2867048T3
(es)
|
2012-06-15 |
2021-10-20 |
Concert Pharmaceuticals Inc |
Derivados deuterados de ruxolitinib
|
|
CA2908929C
(en)
|
2012-07-12 |
2021-01-26 |
Concert Pharmaceuticals, Inc. |
Deuterated idebenone
|
|
BR112015003153A2
(pt)
|
2012-08-17 |
2017-07-04 |
Concert Pharmaceuticals Inc |
baricitinib deuterado
|
|
WO2014078842A1
(en)
|
2012-11-19 |
2014-05-22 |
Concert Pharmaceuticals, Inc. |
Deuterated cftr potentiators
|
|
US20150299166A1
(en)
|
2012-12-20 |
2015-10-22 |
Concert Pharmaceuticals, Inc. |
Deuterated alk inhibitors
|
|
US9789126B2
(en)
|
2012-12-21 |
2017-10-17 |
Mayo Foundation For Medical Education And Research |
Methods and materials for treating calcific aortic valve stenosis
|
|
WO2014110322A2
(en)
|
2013-01-11 |
2014-07-17 |
Concert Pharmaceuticals, Inc. |
Substituted dioxopiperidinyl phthalimide derivatives
|
|
WO2014150043A1
(en)
|
2013-03-15 |
2014-09-25 |
Concert Pharmaceuticals Inc. |
Inhibitors of the enzyme udp-glucose: n-acyl-sphingosine glucosyltransferase
|
|
AU2014235462C1
(en)
|
2013-03-15 |
2018-11-01 |
Concert Pharmaceuticals, Inc. |
Deuterated palbociclib
|
|
HU231191B1
(hu)
|
2013-04-15 |
2021-08-30 |
Szegedi Tudományegyetem |
Izotóp tartalmú morfin molekulák
|
|
WO2015010045A1
(en)
|
2013-07-18 |
2015-01-22 |
Anchor Therapeutics, Inc. |
Apj receptor compounds
|
|
WO2015009889A1
(en)
|
2013-07-18 |
2015-01-22 |
Concert Pharmaceuticals, Inc. |
Deuterated intedanib derivatives and their use for the treatment of proliferative disorders
|
|
WO2015031741A1
(en)
|
2013-08-30 |
2015-03-05 |
Concert Pharmaceuticals, Inc. |
Deuterated derivatives of a thienotriazolodiazapine bromodomain-containing protein inhibitor
|
|
WO2015063670A1
(en)
*
|
2013-10-30 |
2015-05-07 |
Wockhardt Limited |
Solid oral modified-release composition comprising oxcarbazepine or a pharmaceutically acceptable salt thereof
|
|
JP6526060B2
(ja)
|
2014-02-10 |
2019-06-05 |
コンサート ファーマシューティカルズ インコーポレイテッド |
置換トリアゾロベンゾジアゼピン
|
|
US20170216296A1
(en)
|
2014-04-18 |
2017-08-03 |
Concert Pharmaceuticals, Inc. |
Methods of treating hyperglycemia
|
|
WO2015179772A1
(en)
|
2014-05-23 |
2015-11-26 |
Concert Pharmaceuticals, Inc. |
Deuterated phenylquinazolinone and phenylisoquinolinone compounds
|
|
CN106459004B
(zh)
|
2014-06-06 |
2020-09-15 |
研究三角协会 |
爱帕琳肽受体(apj)激动剂及其用途
|
|
WO2016022955A1
(en)
|
2014-08-07 |
2016-02-11 |
Mayo Foundation For Medical Education And Research |
Compounds and methods for treating cancer
|
|
WO2016061488A1
(en)
|
2014-10-17 |
2016-04-21 |
Concert Pharmaceuticals, Inc. |
Amine reuptake inhibitors
|
|
WO2016073545A1
(en)
|
2014-11-06 |
2016-05-12 |
Concert Pharmaceuticals, Inc. |
Phenyloxadiazole benzoic acids
|
|
WO2016089814A1
(en)
|
2014-12-02 |
2016-06-09 |
Concert Pharmaceuticals, Inc. |
Deuterated analogues of daclatasvir
|
|
WO2016105547A1
(en)
|
2014-12-24 |
2016-06-30 |
Concert Pharmaceuticals, Inc. |
Deuterated dasabuvir
|
|
WO2016109795A1
(en)
|
2014-12-31 |
2016-07-07 |
Concert Pharmaceuticals, Inc. |
Deuterated funapide and difluorofunapide
|
|
EP3265440A1
(de)
|
2015-03-06 |
2018-01-10 |
Concert Pharmaceuticals Inc. |
Deuteriertes emricasan
|
|
WO2016160945A1
(en)
|
2015-03-31 |
2016-10-06 |
Concert Pharmaceuticals, Inc. |
Deuterated vx-661
|
|
WO2016176335A1
(en)
|
2015-04-27 |
2016-11-03 |
Concert Pharmaceuticals, Inc. |
Deuterated otx-015
|
|
WO2017020005A1
(en)
|
2015-07-30 |
2017-02-02 |
Concert Pharmaceuticals, Inc. |
Morphinan compounds for use in treating agitation
|
|
US20180243289A1
(en)
|
2015-07-30 |
2018-08-30 |
Concert Pharmaceuticals, Inc. |
Deuterated morphinan compounds for treating agitation
|
|
US20180353500A1
(en)
|
2015-09-21 |
2018-12-13 |
Vertex Pharmaceuticals (Europe) Limited |
Administration of deuterated cftr potentiators
|
|
EP3377179B1
(de)
|
2015-11-19 |
2021-04-07 |
Concert Pharmaceuticals Inc. |
Deuteriertes epi-743
|
|
PE20190258A1
(es)
|
2015-12-09 |
2019-02-25 |
Res Triangle Inst |
Antagonistas del receptor de la apelina (apj) mejorados y usos de los mismos
|
|
WO2017147003A1
(en)
|
2016-02-26 |
2017-08-31 |
Novobiotic Pharmaceuticals, Llc |
Novel macrocyclic antibiotics and uses thereof
|
|
HRP20241345T1
(hr)
|
2016-05-04 |
2024-12-20 |
Sun Pharmaceutical Industries, Inc. |
Liječenje poremećaja gubitka kose deuteriranim inhibitorima jak
|
|
PT3825307T
(pt)
|
2016-07-04 |
2022-08-26 |
Avanir Pharmaceuticals Inc |
Métodos para a síntese de dextrometorfano deuterado
|
|
EP3490538A4
(de)
|
2016-08-01 |
2020-03-18 |
The Brigham and Women's Hospital, Inc. |
Partikel zur verabreichung von proteinen und peptiden
|
|
ES3036483T3
(en)
|
2017-02-28 |
2025-09-19 |
Mayo Found Medical Education & Res |
Combinations for use in the treatment of cancer
|
|
US11278025B2
(en)
|
2017-05-17 |
2022-03-22 |
The General Hospital Corporation |
Antibiotic compounds
|
|
CA3063953A1
(en)
|
2017-05-19 |
2018-11-22 |
Superb Wisdom Limited |
Derivatives of resiquimod
|
|
AU2018371784B2
(en)
|
2017-11-22 |
2024-10-17 |
Sun Pharmaceutical Industries, Inc. |
Deuterated analogs of D-serine and uses thereof
|
|
US11243207B2
(en)
|
2018-03-29 |
2022-02-08 |
Mayo Foundation For Medical Education And Research |
Assessing and treating cancer
|
|
KR20210150495A
(ko)
|
2019-04-10 |
2021-12-10 |
메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 |
심혈관 기능장애의 성별-의존적 치료를 위한 방법 및 재료
|
|
US20220387311A1
(en)
*
|
2019-11-08 |
2022-12-08 |
Lyndra Therapeutics, Inc. |
Gastric residence systems for administration of active agents
|
|
WO2021236139A1
(en)
|
2020-05-21 |
2021-11-25 |
Concert Pharmaceuticals, Inc. |
Novel deuterated jak inhibitor and uses thereof
|
|
WO2021243015A1
(en)
|
2020-05-27 |
2021-12-02 |
The Penn State Research Foundation |
Antibacterial compounds
|
|
EP4236956A1
(de)
|
2020-10-28 |
2023-09-06 |
Sun Pharmaceutical Industries, Inc. |
Behandlungsschemata zur behandlung von haarausfallerkrankungen mit deuterierten jak-hemmern
|
|
AU2022225215A1
(en)
|
2021-02-25 |
2023-08-31 |
Research Triangle Institute |
Heteroaryl derivatives as apelin receptor agonists
|
|
AU2022328272A1
(en)
|
2021-08-11 |
2024-02-22 |
Sun Pharmaceutical Industries, Inc. |
Treatment of hair loss disorders with deuterated jak inhibitors
|
|
WO2023018954A1
(en)
|
2021-08-12 |
2023-02-16 |
Concert Pharmaceuticals, Inc. |
Treatment of jak-inhibition-responsive disorders with prodrugs of jak inhibitors
|
|
US20250275977A1
(en)
|
2022-05-04 |
2025-09-04 |
Sun Pharmaceutical Industries, Inc. |
Dosage regimens for treatment with deuterated jak inhibitors
|